Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Amarin Corp Ads (NQ: AMRN)
17.20 USD  -0.34 (-1.94%)
Official Closing Price  /  Updated: 7:54 PM EST, Feb 20, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 3,608,000
Open 17.68
Bid (Size) 17.20 (1)
Ask (Size) 17.34 (3)
Prev. Close 17.54
Today's Range 17.11 - 17.82
52wk Range 2.350 - 23.33
Shares Outstanding 293,584,140
Dividend Yield N/A
Performance
YTD
+32.21%
+32.21%
1 Month
-1.83%
-1.83%
3 Month
-9.33%
-9.33%
6 Month
+489.04%
+489.04%
1 Year
+364.86%
+364.86%
Featured News
More News
Amarin – 400% Growth And More On The Way
Amarin Corporation, Plc. is up 467% since the end of September. Really, that’s the only way to start a story on this small biopharmaceutical company. Read More
category Pharma/Biotech , Healthcare , Stocks / Equities
from Blogs - TalkMarkets
Biotech Bear Market: But Is It Time to Start Trading?
The NASDAQ is down 1.6% and the Russell 2000 is down 1.8%, killing hopes of a continued Post-Election rally. The biotech sector is for experienced traders only. Healthcare still looks good overall with... Read More
category Healthcare , Pharma/Biotech
from Blogs - TalkMarkets
Featured News
Read More
5 Top Healthcare Mutual Funds To Buy In October
category Mutual Funds , Stocks / Equities
from Blogs - TalkMarkets
5 Best Biotech Stocks To Buy In October
category Stocks / Equities , Pharma/Biotech , Healthcare
from Blogs - TalkMarkets
Most Active Equity Options And Strikes For Midday - Tuesday, Sept. 26
category Options
from Blogs - TalkMarkets
Week In Review: Sinocare Eyes $4 Billion Deal For J&J Diabetes Device Business
category Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
Here Are 5 ‘Strong Buy’ Stocks For Under $10
category Pharma/Biotech , Stocks / Equities , Capital & Industrial Goods
from Blogs - TalkMarkets
Morning Call For Tuesday, Nov. 14
category Stocks / Equities , Currencies/Forex , Bonds , and 1 more.
from Blogs - TalkMarkets
More News
Read More
Amarin To Report Fourth Quarter and Full Year 2018 Results and Host Conference Call on February 27, 2019
from GlobeNewswire News Releases
Amarin to Present at the 8th Annual SVB Leerink Global Healthcare Conference
from GlobeNewswire News Releases
Analysis: Positioning to Benefit within Amarin, Retrophin, Sunrun, BioSpecifics Technologies, Arbutus Biopharma, and TOCAGEN INC — Research Highlights Growth, Revenue, and Consolidated Results
from GlobeNewswire News Releases
New REDUCE-IT™ Trial Data Showing the Total Reduction in Ischemic Events Accepted for Presentation at the American College of Cardiology’s 68th Annual Scientific Session
from GlobeNewswire News Releases
Pharma Catches Another Case Of M&A Fever
category Biotech , ETFs , AMRN , and 22 more.
from Benzinga
2 Healthcare Stocks Ripe for a Takeover
category GGBXF , NVO , AMGN , and 8 more.
from Motley Fool
Why Amarin Stock Jumped 29% in January After Soaring 239% Last Year
category Market News , AMRN
from Motley Fool
Your first trade for Thursday, January 24
category Xilinx Inc , Markets , Stock markets , and 7 more.
from CNBC.com News
Amarin, Caterpillar, McDonald's, Xilinx: 'Fast Money' Picks For January 24
category Options Action , Media , Tim Seymour , and 11 more.
from Benzinga
The Biggest Biotech Binary Event in 2019 Is Just Around the Corner
category ICPT , Market News , AMRN , and 1 more.
from Motley Fool
ADRU's Underlying Holdings Could Mean 16% Gain Potential
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.